Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
BO1:FRA
BioCryst Pharmaceuticals Inc
€7.40
-2.73%
(-0.21) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BO1...
Open
€7.40
High
€7.40
Low
€7.40
Mkt. cap
2.24B
Avg. vol.
252.00
Volume
0.00
52-wk high
€10.18
52-wk low
€5.18
No. of employees
435
News stories
From sources across the web
Profile
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
About BioCryst Pharmaceuticals Inc
CEOJon P. Stonehouse
Employees435
Founded1986
HeadquartersDurham, North Carolina, United States
SectorBiotechnology
Websitebiocryst.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
145.53M
163.35M
159.40M
406.56M
Cost of goods sold
41.84M
46.18M
46.79M
48.35M
Cost of revenue
41.84M
46.18M
46.79M
48.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82.47M
87.38M
83.01M
91.51M
Operating expense
82.47M
87.38M
83.01M
91.51M
Total operating expenses
124.31M
133.57M
129.80M
139.86M
Operating income
21.23M
29.79M
29.59M
266.70M
Other non operating income
-
-
2.67M
5.86M
EBT including unusual items
758.00K
6.49M
12.13M
248.02M
EBT excluding unusual items
758.00K
10.66M
14.87M
261.19M
Income tax expense
726.00K
1.40M
-769.00K
2.17M
Effective tax rate
95.78%
21.60%
-6.34%
0.88%
Other operating expenses
-
-
-
-
Net income
32.00K
5.08M
12.90M
245.84M
Net profit margin
0.02%
3.11%
8.09%
60.47%
Earnings per share
-
0.04
0.16
0.21
Interest and investment income
3.02M
2.52M
2.24M
2.89M
Interest expense
-23.49M
-21.58M
-19.66M
-14.14M
Net interest expenses
-20.47M
-19.07M
-17.42M
-11.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.56M
30.12M
31.56M
267.55M
Gain or loss from assets sale
-
-
-550.00K
-3.57M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer